{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:25:13Z","timestamp":1778541913791,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13170-4","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:26:59Z","timestamp":1774952819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The length of hospital stay in COVID-19 patients using pre-hospital metformin at a Saudi tertiary hospital: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Razaz A.","family":"Felemban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha S.","family":"Mayet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyad O.","family":"Khaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazeed H.","family":"Aljabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman F.","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Althubaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duaa","family":"Babaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"13170_CR1","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R, Features. Evaluation, and Treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Dec 21]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554776\/."},{"issue":"3","key":"13170_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.36922\/MI025190042","volume":"2","author":"S Al-Baidhani","year":"2025","unstructured":"Al-Baidhani S, Sabra T, Al-Baidhani A, Sallam M, Sallam M. A proposal for biologically relevant classification of SARS-CoV-2 variants. Microbes Immun. 2025;2(3):87.","journal-title":"Microbes Immun"},{"key":"13170_CR3","unstructured":"World Health Organization. COVID-19 cases: WHO COVID-19 dashboard [Internet]. Geneva: World Health Organization; [cited 2025 Dec 21]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"issue":"1","key":"13170_CR4","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","volume":"2","author":"CT Bramante","year":"2021","unstructured":"Bramante CT, Ingraham NE, Murray TA, Marmor S, Hovertsen S, Gronski J, et al. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. Lancet Healthy Longev. 2021;2(1):e34\u201341.","journal-title":"Lancet Healthy Longev"},{"key":"13170_CR5","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2147\/DMSO.S417925","volume":"16","author":"Z Guo","year":"2023","unstructured":"Guo Z, Gao Y, Xie E, Ye Z, Li Y, Zhao X, et al. Effects of Metformin on COVID-19 Patients with Type 2 Diabetes: A Retrospective Study. Diabetes Metab Syndr Obes Targets Ther. 2023;16:2573\u201382.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"5","key":"13170_CR6","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.dsx.2021.102231","volume":"15","author":"AA Robert","year":"2021","unstructured":"Robert AA, Al Saeed A, Al Dawish MA. COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives. Diabetes Metab Syndr. 2021;15(5):102231.","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"13170_CR7","first-page":"442","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442\u20139.","journal-title":"Curr Diabetes Rev"},{"issue":"Suppl 1","key":"13170_CR8","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62\u201369.","journal-title":"Diabetes Care"},{"issue":"6","key":"13170_CR9","doi-asserted-by":"publisher","first-page":"147916412110588","DOI":"10.1177\/14791641211058856","volume":"18","author":"S Thipsawat","year":"2021","unstructured":"Thipsawat S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis Res. 2021;18(6):14791641211058856.","journal-title":"Diab Vasc Dis Res"},{"key":"13170_CR10","doi-asserted-by":"crossref","unstructured":"Bai Y, Chi K, Zhao D, Shen W, Liu R, Hao J, et al. Identification of functional heterogeneity of immune cells and tubular-immune cellular interplay action in diabetic kidney disease. J Transl Intern Med. 2024;12(4):395\u2013405.","DOI":"10.2478\/jtim-2023-0130"},{"issue":"2","key":"13170_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2478\/jtim-2024-0006","volume":"12","author":"X Yang","year":"2024","unstructured":"Yang X, Su G, Zhang T, Yang H, Tao H, Du X, et al. Comparison of admission glycemic variability and glycosylated hemoglobin in predicting major adverse cardiac events among type 2 diabetes patients with heart failure following acute ST-segment elevation myocardial infarction. J Transl Intern Med. 2024;12(2):188\u201396.","journal-title":"J Transl Intern Med"},{"key":"13170_CR12","doi-asserted-by":"crossref","unstructured":"Xiao Y, Yu B, Chao C, Wang S, Hu D, Wu C, et al. Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition). J Transl Intern Med. 2024;12(4):325\u201343.","DOI":"10.2478\/jtim-2024-0014"},{"key":"13170_CR13","doi-asserted-by":"crossref","unstructured":"Norouzi M, Norouzi S, Ruggiero A, Khan MS, Myers S, Kavanagh K, et al. Type-2 diabetes as a risk factor for severe COVID-19 infection. Microorganisms. 2021 June 3;9(6):1211.","DOI":"10.3390\/microorganisms9061211"},{"key":"13170_CR14","doi-asserted-by":"publisher","first-page":"199010","DOI":"10.1016\/j.virusres.2022.199010","volume":"323","author":"H Parthasarathy","year":"2023","unstructured":"Parthasarathy H, Tandel D, Siddiqui AH, Harshan KH. Metformin suppresses SARS-CoV-2 in cell culture. Virus Res. 2023;323:199010.","journal-title":"Virus Res"},{"key":"13170_CR15","doi-asserted-by":"publisher","first-page":"113223","DOI":"10.1016\/j.biopha.2022.113223","volume":"152","author":"C Ventura-L\u00f3pez","year":"2022","unstructured":"Ventura-L\u00f3pez C, Cervantes-Luevano K, Aguirre-S\u00e1nchez JS, Flores-Caballero JC, Alvarez-Delgado C, Bernaldez-Sarabia J, et al. Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial. Biomed Pharmacother Biomedecine Pharmacother. 2022;152:113223.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"13170_CR16","doi-asserted-by":"crossref","unstructured":"Bramante CT, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, et al. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol. 2021;93(7):4273\u20139.","DOI":"10.1002\/jmv.26873"},{"key":"13170_CR17","doi-asserted-by":"publisher","first-page":"704666","DOI":"10.3389\/fmed.2021.704666","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med. 2021;8:704666.","journal-title":"Front Med"},{"issue":"1","key":"13170_CR18","doi-asserted-by":"publisher","first-page":"2425829","DOI":"10.1080\/07853890.2024.2425829","volume":"56","author":"M Somasundaram","year":"2024","unstructured":"Somasundaram M, Mathew SK, Paul S, Kurian SJ, Kunhikatta V, Karanth S, et al. Metformin use and its association with various outcomes in COVID-19 patients with diabetes mellitus: a retrospective cohort study in a tertiary care facility. Ann Med. 2024;56(1):2425829.","journal-title":"Ann Med"},{"issue":"1","key":"13170_CR19","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-025-96294-y","volume":"15","author":"X Chen","year":"2025","unstructured":"Chen X, Shi S, Sun H, Zhou L, Wang H, Li Y, et al. Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals. Sci Rep. 2025;15(1):11340.","journal-title":"Sci Rep"},{"issue":"7","key":"13170_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/jcm13071874","volume":"13","author":"GA Silverii","year":"2024","unstructured":"Silverii GA, Fumagalli C, Rozzini R, Milani M, Mannucci E, Marchionni N. Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? J Clin Med. 2024;13(7):1874.","journal-title":"J Clin Med"},{"issue":"1","key":"13170_CR21","first-page":"e77288","volume":"17","author":"B Benfathallah","year":"2025","unstructured":"Benfathallah B, Cherkani Hassani A, El Hilali S, Abouqal R, Benchekroun L. Does the Consumption of Metformin Correlate With a Reduction in Mortality Among Patients With Type 2 Diabetes and COVID-19 in Morocco? Cureus. 2025;17(1):e77288.","journal-title":"Cureus"},{"issue":"1","key":"13170_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12902-018-0244-4","volume":"18","author":"K Al-Rubeaan","year":"2018","unstructured":"Al-Rubeaan K, Bawazeer N, Al Farsi Y, Youssef AM, Al-Yahya AA, AlQumaidi H, et al. Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study. BMC Endocr Disord. 2018;18(1):16.","journal-title":"BMC Endocr Disord"},{"key":"13170_CR23","doi-asserted-by":"publisher","first-page":"810914","DOI":"10.3389\/fendo.2022.810914","volume":"13","author":"CKH Wong","year":"2022","unstructured":"Wong CKH, Lui DTW, Lui AYC, Low MCH, Kwok ACY, Lau KTK, et al. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort. Front Endocrinol. 2022;13:810914.","journal-title":"Front Endocrinol"},{"key":"13170_CR24","doi-asserted-by":"crossref","unstructured":"Erickson SM, Fenno SL, Barzilai N, Kuchel G, Bartley JM, Justice JN, et al. Metformin for treatment of acute COVID-19: Systematic review of clinical trial data against SARS-CoV-2. Diabetes Care. 2023;46(7):1432\u201342.","DOI":"10.2337\/dc22-2539"},{"key":"13170_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2014.05.003","volume":"737","author":"H Soraya","year":"2014","unstructured":"Soraya H, Clanachan AS, Rameshrad M, Maleki-Dizaji N, Ghazi-Khansari M, Garjani A. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. Eur J Pharmacol. 2014;737:77\u201384.","journal-title":"Eur J Pharmacol"},{"key":"13170_CR26","doi-asserted-by":"crossref","unstructured":"Ganesh A, Randall MD. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? a systematic review and meta-analysis. Br J Clin Pharmacol. 2022;88(6):2642\u201356.","DOI":"10.1111\/bcp.15258"},{"key":"13170_CR27","doi-asserted-by":"crossref","unstructured":"Xian H, Liu Y, Rundberg Nilsson A, Gatchalian R, Crother TR, Tourtellotte WG, et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immun 2021;54(7):1463\u2013e147711.","DOI":"10.1016\/j.immuni.2021.05.004"},{"key":"13170_CR28","doi-asserted-by":"crossref","unstructured":"Ibrahim S, Lowe JR, Bramante CT, Shah S, Klatt NR, Sherwood N, et al. Metformin and Covid-19: Focused review of mechanisms and current literature suggesting benefit. Front Endocrinol 2021;12:587801.","DOI":"10.3389\/fendo.2021.587801"},{"issue":"11","key":"13170_CR29","first-page":"1288","volume":"25","author":"P Rangappa","year":"2021","unstructured":"Rangappa P. Cytokine Storm and Immunomodulation in COVID-19. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2021;25(11):1288\u201391.","journal-title":"Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med"},{"issue":"10","key":"13170_CR30","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.18632\/aging.103347","volume":"12","author":"JA Menendez","year":"2020","unstructured":"Menendez JA. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine\/thrombotic storm in COVID-19. Aging. 2020;12(10):8760\u20135.","journal-title":"Aging"},{"key":"13170_CR31","doi-asserted-by":"crossref","unstructured":"Wiernsperger N, Al-Salameh A, Cariou B, Lalau JD. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis. Diabetes Metab. 2022;48(4):101359.","DOI":"10.1016\/j.diabet.2022.101359"},{"key":"13170_CR32","doi-asserted-by":"publisher","first-page":"108977","DOI":"10.1016\/j.diabres.2021.108977","volume":"178","author":"W Yang","year":"2021","unstructured":"Yang W, Sun X, Zhang J, Zhang K. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Diabetes Res Clin Pract. 2021;178:108977.","journal-title":"Diabetes Res Clin Pract"},{"key":"13170_CR33","unstructured":"Post COVID-19 condition (long COVID) [Internet]. [cited 2025 Dec 21]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/post-covid-19-condition-long-covid."},{"issue":"1","key":"13170_CR34","first-page":"66","volume":"5","author":"AG Ewing","year":"2025","unstructured":"Ewing AG, Salamon S, Pretorius E, Joffe D, Fox G, Bilodeau S, et al. Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology. Med Rev 2021. 2025;5(1):66\u201375.","journal-title":"Med Rev 2021"},{"issue":"5","key":"13170_CR35","first-page":"367","volume":"4","author":"M Guo","year":"2024","unstructured":"Guo M, Shang S, Li M, Cai G, Li P, Chen X, et al. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev 2021. 2024;4(5):367\u201383.","journal-title":"Med Rev 2021"},{"key":"13170_CR36","doi-asserted-by":"crossref","unstructured":"Bramante C, Buse JB, Huling JD, Lindsell BJB, Stewart C. T, Metformin at the time of Covid-19 infection and risk of long Covid: A Target trial emulation study [Internet]. Preprints; 2025 [cited 2025 Dec 21]. Available from: https:\/\/www.authorea.com\/users\/1004233\/articles\/1364487.","DOI":"10.22541\/au.176418398.81170401\/v1"},{"issue":"1","key":"13170_CR37","doi-asserted-by":"publisher","first-page":"eabc8180","DOI":"10.1126\/sciadv.abc8180","volume":"7","author":"H Li","year":"2021","unstructured":"Li H, Zhao X, Wang Y, Lou X, Chen S, Deng H, et al. Damaged lung gas exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI. Sci Adv. 2021;7(1):eabc8180.","journal-title":"Sci Adv"},{"issue":"19","key":"13170_CR38","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1021\/acs.jpca.4c08800","volume":"129","author":"NM Ariyasingha","year":"2025","unstructured":"Ariyasingha NM, Oladun C, Samoilenko A, Chowdhury MRH, Nantogma S, Shi Z, et al. Parahydrogen-Hyperpolarized Propane-d6 Gas Contrast Agent: T1 Relaxation Dynamics and Pilot Millimeter-Scale Ventilation MRI. J Phys Chem A. 2025;129(19):4275\u201387.","journal-title":"J Phys Chem A"},{"issue":"10","key":"13170_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/cbmi.4c00041","volume":"2","author":"NM Ariyasingha","year":"2024","unstructured":"Ariyasingha NM, Samoilenko A, Chowdhury MRH, Nantogma S, Oladun C, Birchall JR, et al. Developing Hyperpolarized Butane Gas for Ventilation Lung Imaging. Chem Biomed Imaging. 2024;2(10):698\u2013710.","journal-title":"Chem Biomed Imaging"},{"issue":"24","key":"13170_CR40","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1039\/D4AN01029A","volume":"149","author":"MRH Chowdhury","year":"2024","unstructured":"Chowdhury MRH, Oladun C, Ariyasingha NM, Samoilenko A, Bawardi T, Burueva DB, et al. Rapid lung ventilation MRI using parahydrogen-induced polarization of propane gas. Analyst. 2024;149(24):5832\u201342.","journal-title":"Analyst"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13170-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13170-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:59:58Z","timestamp":1778540398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13170-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13170"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13170-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of King Abdullah International Medical Research Center (approval number: IRB\/0387\/24). The confidentiality and anonymity of participants were completely preserved, and only the research team had access to the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"924"}}